Cargando…

A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease

The serotonin receptor 5-HT(1B) is widely expressed in the central nervous system and has been considered a drug target in a variety of cognitive and psychiatric disorders. The anti-inflammatory effects of 5-HT(1B) agonists may present a promising approach for Alzheimer’s disease (AD) treatment. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yang, Zhang, Lijing, Yu, Jiaojiao, Ma, Zhaobin, Li, Moxiang, Wang, Jin, Hu, Pengcheng, Zou, Jia, Liu, Xueying, Liu, Ying, An, Su, Xiang, Cheng, Guo, Xiaoxi, Hao, Qian, Xu, Tian-Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450432/
https://www.ncbi.nlm.nih.gov/pubmed/34552493
http://dx.doi.org/10.3389/fphar.2021.735876
_version_ 1784569645897875456
author Yang, Yang
Zhang, Lijing
Yu, Jiaojiao
Ma, Zhaobin
Li, Moxiang
Wang, Jin
Hu, Pengcheng
Zou, Jia
Liu, Xueying
Liu, Ying
An, Su
Xiang, Cheng
Guo, Xiaoxi
Hao, Qian
Xu, Tian-Rui
author_facet Yang, Yang
Zhang, Lijing
Yu, Jiaojiao
Ma, Zhaobin
Li, Moxiang
Wang, Jin
Hu, Pengcheng
Zou, Jia
Liu, Xueying
Liu, Ying
An, Su
Xiang, Cheng
Guo, Xiaoxi
Hao, Qian
Xu, Tian-Rui
author_sort Yang, Yang
collection PubMed
description The serotonin receptor 5-HT(1B) is widely expressed in the central nervous system and has been considered a drug target in a variety of cognitive and psychiatric disorders. The anti-inflammatory effects of 5-HT(1B) agonists may present a promising approach for Alzheimer’s disease (AD) treatment. Herbal antidepressants used in the treatment of AD have shown functional overlap between the active compounds and 5-HT(1B) receptor stimulation. Therefore, compounds in these medicinal plants that target and stimulate 5-HT(1B) deserve careful study. Molecular docking, drug affinity responsive target stability, cellular thermal shift assay, fluorescence resonance energy transfer (FRET), and extracellular regulated protein kinases (ERK) 1/2 phosphorylation tests were used to identify emodin-8-O-β-d-glucopyranoside (EG), a compound from Chinese medicinal plants with cognitive deficit attenuating and antidepressant effects, as an agonist of 5-HT(1B). EG selectively targeted 5-HT(1B) and activated the 5-HT(1B)-induced signaling pathway. The activated 5-HT(1B) pathway suppressed tumor necrosis factor (TNF)-α levels, thereby protecting neural cells against beta-amyloid (Aβ)-induced death. Moreover, the agonist activity of EG towards 5-HT(1B) receptor, in FRET and ERK1/2 phosphorylation, was antagonized by SB 224289, a 5-HT(1B) antagonist. In addition, EG relieved AD symptoms in transgenic worm models. These results suggested that 5-HT(1B) receptor activation by EG positively affected Aβ-related inflammatory process regulation and neural death resistance, which were reversed by antagonist SB 224289. The active compounds such as EG might act as potential therapeutic agents through targeting and stimulating 5-HT(1B) receptor for AD and other serotonin-related disorders. This study describes methods for identification of 5-HT(1B) agonists from herbal compounds and for evaluating agonists with biological functions, providing preliminary information on medicinal herbal pharmacology.
format Online
Article
Text
id pubmed-8450432
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84504322021-09-21 A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease Yang, Yang Zhang, Lijing Yu, Jiaojiao Ma, Zhaobin Li, Moxiang Wang, Jin Hu, Pengcheng Zou, Jia Liu, Xueying Liu, Ying An, Su Xiang, Cheng Guo, Xiaoxi Hao, Qian Xu, Tian-Rui Front Pharmacol Pharmacology The serotonin receptor 5-HT(1B) is widely expressed in the central nervous system and has been considered a drug target in a variety of cognitive and psychiatric disorders. The anti-inflammatory effects of 5-HT(1B) agonists may present a promising approach for Alzheimer’s disease (AD) treatment. Herbal antidepressants used in the treatment of AD have shown functional overlap between the active compounds and 5-HT(1B) receptor stimulation. Therefore, compounds in these medicinal plants that target and stimulate 5-HT(1B) deserve careful study. Molecular docking, drug affinity responsive target stability, cellular thermal shift assay, fluorescence resonance energy transfer (FRET), and extracellular regulated protein kinases (ERK) 1/2 phosphorylation tests were used to identify emodin-8-O-β-d-glucopyranoside (EG), a compound from Chinese medicinal plants with cognitive deficit attenuating and antidepressant effects, as an agonist of 5-HT(1B). EG selectively targeted 5-HT(1B) and activated the 5-HT(1B)-induced signaling pathway. The activated 5-HT(1B) pathway suppressed tumor necrosis factor (TNF)-α levels, thereby protecting neural cells against beta-amyloid (Aβ)-induced death. Moreover, the agonist activity of EG towards 5-HT(1B) receptor, in FRET and ERK1/2 phosphorylation, was antagonized by SB 224289, a 5-HT(1B) antagonist. In addition, EG relieved AD symptoms in transgenic worm models. These results suggested that 5-HT(1B) receptor activation by EG positively affected Aβ-related inflammatory process regulation and neural death resistance, which were reversed by antagonist SB 224289. The active compounds such as EG might act as potential therapeutic agents through targeting and stimulating 5-HT(1B) receptor for AD and other serotonin-related disorders. This study describes methods for identification of 5-HT(1B) agonists from herbal compounds and for evaluating agonists with biological functions, providing preliminary information on medicinal herbal pharmacology. Frontiers Media S.A. 2021-09-06 /pmc/articles/PMC8450432/ /pubmed/34552493 http://dx.doi.org/10.3389/fphar.2021.735876 Text en Copyright © 2021 Yang, Zhang, Yu, Ma, Li, Wang, Hu, Zou, Liu, Liu, An, Xiang, Guo, Hao and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Yang, Yang
Zhang, Lijing
Yu, Jiaojiao
Ma, Zhaobin
Li, Moxiang
Wang, Jin
Hu, Pengcheng
Zou, Jia
Liu, Xueying
Liu, Ying
An, Su
Xiang, Cheng
Guo, Xiaoxi
Hao, Qian
Xu, Tian-Rui
A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease
title A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease
title_full A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease
title_fullStr A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease
title_full_unstemmed A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease
title_short A Novel 5-HT(1B) Receptor Agonist of Herbal Compounds and One of the Therapeutic Uses for Alzheimer’s Disease
title_sort novel 5-ht(1b) receptor agonist of herbal compounds and one of the therapeutic uses for alzheimer’s disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450432/
https://www.ncbi.nlm.nih.gov/pubmed/34552493
http://dx.doi.org/10.3389/fphar.2021.735876
work_keys_str_mv AT yangyang anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT zhanglijing anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT yujiaojiao anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT mazhaobin anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT limoxiang anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT wangjin anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT hupengcheng anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT zoujia anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT liuxueying anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT liuying anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT ansu anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT xiangcheng anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT guoxiaoxi anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT haoqian anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT xutianrui anovel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT yangyang novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT zhanglijing novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT yujiaojiao novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT mazhaobin novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT limoxiang novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT wangjin novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT hupengcheng novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT zoujia novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT liuxueying novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT liuying novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT ansu novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT xiangcheng novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT guoxiaoxi novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT haoqian novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease
AT xutianrui novel5ht1breceptoragonistofherbalcompoundsandoneofthetherapeuticusesforalzheimersdisease